Shanghai Aladdin Biochemical TechnologyLtd Crescita futura

Future criteri di controllo 2/6

Si prevede che Shanghai Aladdin Biochemical TechnologyLtd aumenterà i ricavi a una percentuale annua pari a 20.2%.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Chemicals crescita degli utili	39.3%
Tasso di crescita dei ricavi	20.2%
Rendimento futuro del capitale proprio	13.3%
Copertura analitica	Low
Ultimo aggiornamento	10 Sep 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Does Shanghai Aladdin Biochemical TechnologyLtd (SHSE:688179) Have A Healthy Balance Sheet?

Nov 19

Estimating The Fair Value Of Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)

Oct 16

What Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) 34% Share Price Gain Is Not Telling You

Sep 30

Here's What's Concerning About Shanghai Aladdin Biochemical TechnologyLtd's (SHSE:688179) Returns On Capital

Sep 28

Cautious Investors Not Rewarding Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) Performance Completely

Jun 06

Is Now An Opportune Moment To Examine Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)?

Apr 23

Previsioni di crescita degli utili e dei ricavi

SHSE:688179 - Stime future degli analisti e dati finanziari passati (CNY Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	793	N/A	N/A	162	1
12/31/2025	679	N/A	N/A	88	1
12/31/2024	555	N/A	N/A	131	1
9/30/2024	498	104	114	142	N/A
6/30/2024	456	102	87	124	N/A
3/31/2024	415	86	46	92	N/A
12/31/2023	403	86	10	56	N/A
9/30/2023	395	82	-42	5	N/A
6/30/2023	386	73	-122	-50	N/A
3/31/2023	373	79	-118	-51	N/A
12/31/2022	378	93	-105	-43	N/A
9/30/2022	356	95	-162	-45	N/A
6/30/2022	335	98	-90	-12	N/A
3/31/2022	317	100	-99	3	N/A
12/31/2021	288	89	-98	15	N/A
9/30/2021	272	86	-4	49	N/A
6/30/2021	273	92	22	75	N/A
3/31/2021	261	86	62	88	N/A
12/31/2020	234	74	72	81	N/A
9/30/2020	223	68	62	70	N/A
6/30/2020	206	59	56	63	N/A
3/31/2020	203	60	47	54	N/A
12/31/2019	210	64	50	56	N/A
9/30/2019	200	64	52	63	N/A
6/30/2019	188	60	34	46	N/A
3/31/2019	176	61	21	35	N/A
1/1/2019	166	53	28	39	N/A
9/30/2018	158	46	2	5	N/A
6/30/2018	148	44	N/A	24	N/A
3/31/2018	137	34	N/A	29	N/A
1/1/2018	126	32	N/A	33	N/A
9/30/2017	112	26	N/A	41	N/A
6/30/2017	111	24	N/A	39	N/A
3/31/2017	105	23	N/A	31	N/A
1/1/2017	106	21	N/A	31	N/A
9/30/2016	105	25	N/A	27	N/A
6/30/2016	104	28	N/A	22	N/A
3/31/2016	102	29	N/A	16	N/A
1/1/2016	101	30	N/A	10	N/A
9/30/2015	94	27	N/A	12	N/A
6/30/2015	87	25	N/A	14	N/A
3/31/2015	84	25	N/A	23	N/A
12/31/2014	80	25	N/A	31	N/A
9/30/2014	77	23	N/A	28	N/A
6/30/2014	73	21	N/A	24	N/A
3/31/2014	69	20	N/A	17	N/A
1/1/2014	65	19	N/A	10	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista 688179 è superiore al tasso di risparmio ( 2.8% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di 688179 cresceranno più velocemente del mercato CN

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di 688179 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di 688179 ( 20.2% all'anno) crescerà più rapidamente del mercato CN ( 13.9% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 688179 ( 20.2% all'anno) crescerà più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 688179 sarà basso tra 3 anni ( 13.3 %).

Shanghai Aladdin Biochemical TechnologyLtd Crescita futura

Future criteri di controllo 2/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

Does Shanghai Aladdin Biochemical TechnologyLtd (SHSE:688179) Have A Healthy Balance Sheet?

Third quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.085 in 3Q 2023)

Estimating The Fair Value Of Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)

Investor sentiment deteriorates as stock falls 18%

What Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) 34% Share Price Gain Is Not Telling You

New minor risk - Share price stability

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Here's What's Concerning About Shanghai Aladdin Biochemical TechnologyLtd's (SHSE:688179) Returns On Capital

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.053 in 2Q 2023)

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179) announces an Equity Buyback for CNY 15 million worth of its shares.

Cautious Investors Not Rewarding Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) Performance Completely

First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.086 in 1Q 2023)

Is Now An Opportune Moment To Examine Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)?

Shanghai Aladdin Biochemical Technology Co.,Ltd., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.074 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.074 (vs CN¥0.099 in 2Q 2022)

Investor sentiment deteriorates as stock falls 29%

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.22 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.67 (vs CN¥0.64 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.13 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.15 in 2Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.20 in 1Q 2021)

Full year 2021 earnings released: EPS: CN¥0.89 (vs CN¥0.93 in FY 2020)

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.32 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.21 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.93 (vs CN¥0.84 in FY 2019)

New 90-day high: CN¥106

Market bids up stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita